EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.1.1.1 | cytosol | - |
Mus musculus | 5829 | - |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.1 | S-adenosyl-L-methionine + nicotinamide | Mus musculus | - |
S-adenosyl-L-homocysteine + 1-methylnicotinamide | - |
? | |
2.1.1.1 | S-adenosyl-L-methionine + nicotinamide | Mus musculus C57/BL6J | - |
S-adenosyl-L-homocysteine + 1-methylnicotinamide | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.1 | Mus musculus | - |
C57BL/6J mice | - |
2.1.1.1 | Mus musculus C57/BL6J | - |
C57BL/6J mice | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.1.1 | adipose tissue | - |
Mus musculus | - |
2.1.1.1 | adrenal gland | - |
Mus musculus | - |
2.1.1.1 | brain | - |
Mus musculus | - |
2.1.1.1 | carcinoma cell | - |
Mus musculus | - |
2.1.1.1 | heart | - |
Mus musculus | - |
2.1.1.1 | kidney | - |
Mus musculus | - |
2.1.1.1 | liver | high enzyme activity. Enzyme upregulation in vascular inflammation and atherosclerosis, overview | Mus musculus | - |
2.1.1.1 | lung | - |
Mus musculus | - |
2.1.1.1 | placenta | - |
Mus musculus | - |
2.1.1.1 | skeletal muscle | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.1 | S-adenosyl-L-methionine + 4-methylnicotinamide | assay for fluorometric determination of enzyme activity | Mus musculus | S-adenosyl-L-homocysteine + 1,4-dimethylnicotinamide | - |
? | |
2.1.1.1 | S-adenosyl-L-methionine + 4-methylnicotinamide | assay for fluorometric determination of enzyme activity | Mus musculus C57/BL6J | S-adenosyl-L-homocysteine + 1,4-dimethylnicotinamide | - |
? | |
2.1.1.1 | S-adenosyl-L-methionine + nicotinamide | - |
Mus musculus | S-adenosyl-L-homocysteine + 1-methylnicotinamide | - |
? | |
2.1.1.1 | S-adenosyl-L-methionine + nicotinamide | - |
Mus musculus C57/BL6J | S-adenosyl-L-homocysteine + 1-methylnicotinamide | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.1 | NNMT | - |
Mus musculus |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.1.1.1 | 37 | - |
assay at | Mus musculus |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
2.1.1.1 | 8.6 | - |
assay at, substrate 4-methoxybenzaldehyde | Mus musculus |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.1.1.1 | S-adenosyl-L-methionine | - |
Mus musculus |
EC Number | Organism | Comment | Expression |
---|---|---|---|
2.1.1.1 | Mus musculus | progression of vascular inflammation and atherosclerosis is associated with the upregulation of hepatic NNMT activity and subsequent increase in endogenous 1-methylnicotinamide plasma levels | up |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.1.1.1 | physiological function | progression of vascular inflammation and atherosclerosis is associated with the upregulation of hepatic NNMT activity and subsequent increase in endogenous 1-methylnicotinamide plasma levels | Mus musculus |